Introduction
Thin-layer chromatography (TLC) used to be a leading chromatographic technique that is still very popular in pharmaceutical analysis. Unfortunately, the chromatographic analysis of basic drugs is often complicated because of the effect of free silanols on retention (1, 2) . This is probably due to the ionic interactions of the positively charged analytes with the free silanol groups on silica or alkyl-bonded-silica stationary phases. The ion-exchange interaction causes a strong retention of basic analytes, resulting in poor peak or spot shape and tailing. Hence, the addition of different buffer salts and various amines such as triethylamine (TEA) or dimethyloctylamine (DMOA) is often needed to improve chromatographic results (3) .
Studies described in the last decade show that ionic liquids (ILs) can be used in a great variety of applications. Because of their unique and flexible physical and chemical properties, they are innovative solvents and are often considered in green chemistry ideas. Numerous reviews have described recent efforts in the application of ILs in almost all areas of analytical chemistry (4 -8) . ILs are organic salts with low melting points, called neoteric solvents, that are also finding new applications as additives in chromatographic techniques (9 -11). The most commonly employed ILs in liquid chromatography are composed of alkylammonium and imidazolium cations, which are soluble in common chromatographic solvents (12-14). Also, the ILs based on the BF 4 
2
, Cl 2 and MeSO 4 2 anions are waterstable compounds, which dissolve in typical chromatographic mobile phases.
Recently, ILs have been proposed as silanol suppressing agents (15, 16) . The significant effects of imidazolium-based ILs as mobile phase modifiers in thinlayer chromatography (TLC) and high-performance liquid chromatography (HPLC) on the retention of basic compounds have been studied and described elsewhere (13) . The addition of 0.5 -2.5% (v/v) of some types of ILs composed of 1,3-dimethylimidazolium, 1-ethyl-3-methylimidazolium, 1-propyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-octyl-3-methylimidazolium or 1-butyl-4-methylpyridinium cations and bromide chlorate, hexafluorophosphate, methyl sulphate, tetrafluoroborate or tosylate anions more markedly decreased the retention of basic analytes than other alkylamines (17 -21). The experiments have been evaluated by primarily using octadecyl-silica stationary phases with a strong or moderate silanol activity. The retention mechanism of studied compounds is very complex because of the dual nature of ILs. Both parts of the salts, cation and anion, can affect the chromatographic retention. The oppositely charged ions can cause synergistic or antagonistic effects (22) . It has been demonstrated that both cations and anions of ILs can be adsorbed on hydrophobic stationary phases. However, the authors' previous studies demonstrated the significant influence of 1-alkyl-3-methylimidazolium cation on the silanol suppressing properties of ILs (14) . The 1-alkyl-3-methylimidazolium tetrafluoroborate IL provided better silanol blocking activity on the bare silica or octadecyl silica TLC plates than ammonia and ternary amines (TEA, DMOA). Hence, the silanol suppressing effect was successfully used for the qualification of basic drugs and for the optimization of separation of peptides in TLC plates (14, 23) .
Until now, most studies describing the use of ILs as mobile phase modifiers in LC have been related to qualification analysis with regard to the evaluation of their silanol suppressing potency. The primary aim of this study is the application of previously selected ILs in quantification HPTLC analysis of naphazoline nitrate in nasal drops. Naphazoline nitrate is a basic drug that causes analytical problems during the chromatographic process on silica based stationary phasess. Several methods for the determination of naphazoline and other a-adrenergic agents have been validated and described in literature. Naphazoline, phenylephrine, tetrahydrozoline, tramazoline, tymazoline and xylomethazoline were determined as single active compounds or mixtures in commercial preparations in nasal and ophthalmic solutions using HPLC and capillary electrophoresis (CE) (24) . Also, except for the pharmaceutical compound analysis, the determination of the a-adrenergic drugs in the presence of other chemicals as preservatives in pharmaceutical preparations have been described (25, 26) . Numerous silica-based stationary normal and reverse phases have been tested to improve the chromatographic separation and qualification of 2-imidazolidine drugs. However, most of the tested chromatographic systems were based on ammonia and adsorbable amino quenchers (e.g., triethylamine or tetramethylammonium bromide) as mobile phase modifiers to suppress free silanol effects. This study describes an application of imidazolium-based ILs to reduce the deleterious effects of free silanols on LC separation of naphazoline nitrate. Replacement of the commonly used alkylamine additives with the readily available ILs may improve chromatographic separations of the problem-causing chemicals. The use of ILs is justified and can be recommended instead of the currently employed environmentally harmful agents. Finally, in the present study, a novel, simple HPLC-ultraviolet (UV)-densitometric method was developed for the determination of naphazoline nitrate in commercially available pharmaceutical preparation.
Experimental

Chemicals
1-Ethyl-3-methylimidazolium tetrafluoroborate ([emim][BF 4 ]) and 1-hexyl-3-methylimidazolium tetrafluoroborate ([hmim][BF 4 ])
were purchased from Fluka Chemika (Buchs, Switzerland) ( Figure 1 ). The reference standard of naphazoline nitrate was acquired from POCh (Gliwice, Poland). Rhinazin drops consisting of 1 mg/mL naphazoline nitrate were from Polfa Warszawa (Warsaw, Poland). Acetonitrile, methanol, sodium chloride, tetrahydrofuran and water were purchased from POCh. The water used in the study was prepared using a Milli-Q Water Purification System (Millipore, Bedford, MA).
Methods HPTLC was performed on glass plates covered with silica gel plates with F 254S and RP-18 with F 254S (10cm x 20cm) purchased from Merck (Darmstadt, Germany). Spotting of the analytes onto the HPTLC plates was performed by Desaga AS 30 HPTLC applicator (Wiesloch, Germany) with injection volume of 1 mL/spot and application rate of 14 s/mL. The resulting spot size was 4 mm and the distance between center spots was 13 mm. The distance between the start line and the bend line of the plate was 1 cm.
The plates were developed in a horizontal chamber (Modin, Lublin, Poland) that was saturated with the respective mobile phases. The mobile phase consisted of acetonitrile -water (6: 4 ]. Visualization was performed by a CabUV-Vis (Desaga, Wiesloch, Germany), and documented using Canon Power Shot G5 connected to a PC with ProViDoc 3.0 software (Desaga). The determination of naphazoline nitrate was executed using CD 60 HPTLC densitometer connected to a PC with ProQuant software (Desaga) at a wavelength of 276 nm. The size of the scanning light beam was set at 0.02 mm for the slit height and 0.4 mm for slit width. The 10 mm/s scanning rate was used to obtain resolution of 25 mm.
The wavelength of maximum absorption was determined by a scan of the assayed drug spot (1 mL/spot) on the HPTLC plate ( Figure 2) .
Measurements of mobile phase UV absorbance were performed using a Shimadzu Prominence system (Kyoto, Japan) composed of a diode array detector (SPD-M20A). Standard solutions and analytical procedure for the assay of naphazoline nitrate A stock solution of naphazoline nitrate (1.2 mg/mL) was prepared in methanol. The calibration samples were prepared in methanol in triplicate in the following concentrations: 0.20, 0.30, 0.45, 0.60, 0.75, 0.90 and 1.05 mg/mL. The developed and dried plates were scanned with a densitometer in the absorbance mode at 276 nm. The calibration curves were set by plotting the peak area against the drug quantity per spot. The equations of calibration curves were estimated using linear regression. Naphazoline nitrate nasal drops (750 mL; 1 mg/mL) were diluted with 250 mL of methanol and water, respectively. 4 ] as novel modifiers of the mobile phase were performed in both normal and reversed-HPTLC stationary phase systems. Based on the previously reported results, the optimal composition of the mobile phase for the application of ILs in the chromatography of selected phenothiazine-derived drugs is determined by acetonitrile -water 60/40 (v/v) (14) . The concentration of ILs was adjusted by the selection of a retardation coefficient (R f ) value and better shapes of spots. The exemplary HPTLC plates with naphazoline nitrate, developed at different conditions, are measurements confirmed that the chromatographic systems are suitable for qualification analysis (Table I) 4 ] is presented in Figure 5 . Parallel with standard solutions, the three spots with both methanolic and aqueous solutions of rhinazin drops were developed on the same plates. The calibration curve equations ( peak area versus drug quantity per spot) were estimated using linear regression analysis, with correlation coefficients presented in Table II 4 ], with mean relative standard deviations (RSDs) of 50.74 and 40.55%, exclude the use of the IL for accurate analysis. In view of the good specificity of both ILs, the high values of RSD can be attributed to hexyl chains in the imidazolium ring, which probably hinder the densitometric detection. Moreover, the previously evaluated silanol-suppressing potency (K A ) showed the greatest effect of octyl-and hexyl-imidazolium-based ILs on the deleterious effect of free silanols (15 Analyzing the data in Table II shows that the dilution of aqueous nasal drops with methanol provides a higher naphazoline recovery due to the contraction effect. Therefore, the aqueous solutions of the studied formulation should be used for accurate determination and quantification of the component drug, naphazoline.
Results and Discussion
Because the determination of naphazoline nitrate in nasal drops was analyzed, the other components, i.e., preservatives, were expected. What is surprising is that no additional spots were detected during the TLC densitometric method. However, based on the reported studies, preservatives like benzalconium chloride are present in very low concentration, while active ingredients are present in considerably greater concentrations. Additionally, the lack of the detection can also be due to the lower absorptivity of benzalkonium chloride than the active ingredient (naphazoline nitrate) (22, 24) .
Conclusion
The presented study demonstrates the application of ILs in TLC-densitometric methods. The use of ILs as modifiers of the mobile phase allowed problems normally encountered in LC of basic analytes to be solved. The results demonstrate that the alkyl-imidazolium class ILs with short alkyl-chain lengths are particularly suitable as modifiers of the mobile phase in the HPTLC determination of naphazoline. The new method can be applied in HPTLC pharmaceutical analysis of basic drugs in their pharmaceutical formulations. The developed approach was demonstrated to provide a reproducible assay of naphazoline nitrate in nasal drops that could not be obtained with the use of standard silanol-suppressing mobile phase additives, like TEA or DMOA. Naturally, the method should be validated for the routine analysis of the known drug analyte in pharmaceutical formulations. 
